Antifungal Treatment for Japanese Patients with Chronic Pulmonary Aspergillosis.

ABSTRACT:

Introduction

Despite the ongoing efforts to refine treatment durations and methods for patients with chronic pulmonary aspergillosis, the clinical use of antifungal agents remains unclear. This study aimed to describe the treatment practices, trajectories, and prognoses of newly diagnosed patients with chronic pulmonary aspergillosis.

Methods

Data from a longitudinal database from hospitals in Japan was used. The target population included patients who started antifungal treatment following their initial diagnosis of pulmonary aspergillosis, pulmonary aspergilloma, or chronic necrotizing pulmonary aspergillosis between October 2015 and September 2017. We described patient characteristics and treatment practices.

Results

Of the 680 patients analyzed, 253 (37.2%), 231 (

SUBMITTER: Takazono T 

PROVIDER: S-EPMC11782703 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature